Company

ACADIA PHARMACEUTICALS INC (ACAD)

Standardized SEC financial data for ACADIA PHARMACEUTICALS INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001070494 · NASDAQ · Pharmaceutical Preparations.

Gross margin

91.7%

Operating margin

9.8%

Net margin

36.5%

Revenue growth (YoY)

11.9%

Return on equity

31.9%

ROIC

4.0%

Free cash flow

$105.1M

Debt / equity

0.00×

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$441.8M	$484.1M	$517.2M	$726.4M	$957.8M	$1.07B
Cost of revenue	$10.2M	$19.1M	$10.2M	$41.6M	$81.8M	$89.0M
Gross profit	$431.5M	$473.3M	$507.1M	$684.8M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$326.0M	$147.4M	$114.8M	$188.7M	$319.6M	$177.7M
Inventory	$9.7M	$14.1M	$11.6M	$40.4M	$91.7M	$111.4M
Total current assets	$717.6M	$617.8M	$507.9M	$616.1M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$136.2M	-$125.7M	-$114.0M	$16.7M	$157.7M	$109.8M
Capital expenditures	$7.6M	$1.1M	$0	$50K	$523K	$4.7M
Free cash flow	-$143.8M	-$126.8M	-$114.0M	$16.7M

Get ACAD data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ACAD/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ACAD/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View ACAD filings on SEC EDGAR →